Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital

Jul 15, 2024•almost 2 years ago

Contract Type

partnership

San DiegoBiotechnologyHealthcareTherapeutics

Description

LENZ Therapeutics, Inc. announces a $30 million private investment in public equity (PIPE) common stock financing from Ridgeback Capital Investments L.P. The investment aims to further strengthen LENZ's Balance Sheet as they continue to develop LNZ100, a potential best-in-class therapeutic option for the treatment of presbyopia.

Company Information

Company

LENZ Therapeutics

Location

445 MARINE VIEW AVE., SUITE #320

San Diego, California, United States

About

LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people with presbyopia. After merging with Graphite Bio, the new combined company will operate under the name LENZ Therapeutics, Inc.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for LENZ Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.